The oncogenic and immunological roles of histidine triad nucleotide-binding protein 1 in human cancers and their experimental validation in the MCF-7 cell line
- PMID: 36846002
- PMCID: PMC9951023
- DOI: 10.21037/atm-22-6637
The oncogenic and immunological roles of histidine triad nucleotide-binding protein 1 in human cancers and their experimental validation in the MCF-7 cell line
Abstract
Background: Histidine triad nucleotide binding protein 1 (HINT1) is a haplo-insufficient tumor suppressor gene that plays a significant role in cell proliferation and survival. However, to date, no systematic pan-cancer analysis has been conducted to explore its function in prognosis, and its oncogenic and immunological roles. We also analyzed the role of HINT1 in breast cancer (BC) progression in vitro.
Methods: An analysis of the HINT1 expression pattern was performed using the TIMER database. The infiltration of immune cells into several cancer types was also studied using the Xena Shiny tool. To determine the relationship between stemness and the expression of HINT1 mRNA, the Spearman correlation test was used with the SangerBox tool. The correlation between HINT1 and functional states in various cancers was determined from the CancerSEA database. The potential role of HINT1 in BC oncogenesis was also investigated by Western blot and Annexin V/PI assays.
Results: The Cancer Genome Atlas pan-cancer data analysis suggested that HINT1 was extensively altered in most tumor tissues but not in most adjacent normal tissues. A high expression of HINT1 was associated with the decreased infiltration of cluster of differentiation (CD)4+ T cells. Importantly, increased HINT1 expression was also associated with a large majority of tumors with high stemness and lower stromal, immune, and estimate scores. Further, the expression of HINT1 was significantly associated with the tumor mutational burden (TMB) and microsatellite instability (MSI) in certain tumor types. Finally, HINT1 overexpression was found to impair BC progression by promoting cell apoptosis. HINT1 upregulation also reduced the expression of microphthalmia transcription factor (MITF) and β-catenin in BC Michigan Cancer Foundation-7 (MCF-7) cells, and the phosphorylation of protein kinase B (p-Akt).
Conclusions: The present study showed that HINT1 plays an oncogenic role in various cancers and could also be used as a biomarker for BC.
Keywords: Histidine triad nucleotide binding protein 1 (HINT1); apoptosis; breast cancer (BC); oncogenic role; tumor microenvironment.
2023 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-6637/coif). The authors have no conflicts of interest to declare.
Figures







Similar articles
-
The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells.Cell Cycle. 2012 Jun 1;11(11):2206-15. doi: 10.4161/cc.20765. Epub 2012 Jun 1. Cell Cycle. 2012. PMID: 22647378
-
Deacetylation by SIRT1 promotes the tumor-suppressive activity of HINT1 by enhancing its binding capacity for β-catenin or MITF in colon cancer and melanoma cells.Exp Mol Med. 2020 Jul;52(7):1075-1089. doi: 10.1038/s12276-020-0465-2. Epub 2020 Jul 7. Exp Mol Med. 2020. PMID: 32636443 Free PMC article.
-
Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells.Oncogene. 2017 Aug 17;36(33):4732-4738. doi: 10.1038/onc.2017.81. Epub 2017 Apr 10. Oncogene. 2017. PMID: 28394346
-
[HINT1--a novel tumor suppressor protein of the HIT superfamily].Postepy Biochem. 2010;56(1):55-60. Postepy Biochem. 2010. PMID: 20499681 Review. Polish.
-
Emerging Roles of Histidine Triad Nucleotide Binding Protein 1 in Neuropsychiatric Diseases.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Oct 30;39(5):705-714. doi: 10.3881/j.issn.1000-503X.2017.05.018. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017. PMID: 29125116 Review. English.
Cited by
-
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer.Biomark Res. 2024 Aug 12;12(1):80. doi: 10.1186/s40364-024-00632-7. Biomark Res. 2024. PMID: 39135097 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous